文献速递青光眼眼底病与葡萄膜炎

青光眼患者血压与黄斑神经节细胞复合体变薄速率的关联

Association of Blood Pressure With Rates of Macular Ganglion Cell Complex Thinning in Patients With Glaucoma.
PubMed 文献 · JAMA Ophthalmol · 2023-01-01

这项前瞻性队列研究纳入105只眼(105例)中央或中重度青光眼损伤患者,评估基线血压指标与黄斑神经节细胞复合体变薄速率的关系。结果显示,在较高眼压下,较低舒张压与更快的复合体变薄相关;在眼压8 mmHg时每降低10 mmHg舒张压对应变薄减慢0.011 μm/年,在眼压16 mmHg时则对应加快-0.130 μm/年。

要点

  • 女性、有降压药使用史、较高眼压、较厚中央角膜厚度、较短眼轴、较高12周/度对比敏感度及较高基线10-2视野平均偏差与更快的复合体变薄相关。
  • 在较高眼压下,较低舒张压与更快的黄斑神经节细胞复合体变薄速率相关。
  • 眼压8 mmHg时每降低10 mmHg舒张压与变薄速率减慢0.011 μm/年相关,眼压16 mmHg时则与加快-0.130 μm/年相关。

核心结论

  • 基线较低舒张压合并较高眼压与更快的黄斑神经节细胞复合体变薄速率相关。
  • 作者认为,若得到适当临床试验支持,这些发现支持在青光眼患者中评估和处理舒张压作为治疗措施。

研究设计与样本

  • 前瞻性队列研究,使用加利福尼亚大学洛杉矶分校晚期青光眼进展研究的数据,开展时间为2021年8月至2022年8月。
  • 纳入39至80岁、超过4次黄斑影像检查且随访2年以上的患者,共105只眼来自105例参与者。
  • 暴露为中央损伤或视野平均偏差差于-6 dB的青光眼诊断。

主要发现

  • 队列平均(SD)年龄66.9(8.5)岁,10-2视野平均偏差-8.3(5.3)dB,随访时间3.6(0.4)年,67例(63.8%)为女性。
  • 种族和民族构成由患者自我报告:非洲裔美国人15例(14.3%)、亚洲人23例(21.9%)、西班牙裔12例(11.4%)、白人55例(52.4%)。
  • 多变量分析中,女性、有降压药使用史、较高眼压、较厚中央角膜厚度、较短眼轴、较高12周/度对比敏感度及较高基线10-2视野平均偏差与更快的复合体变薄相关。
  • 在较高眼压下,较低舒张压与更快的复合体变薄速率相关;眼压8 mmHg(10%分位数)时每降低10 mmHg舒张压与变薄速率减慢0.011 μm/年相关,眼压16 mmHg(90%分位数)时则与加快-0.130 μm/年相关。

临床怎么用

  • 作者认为,若得到适当临床试验支持,这些发现支持在青光眼患者中考虑评估和处理舒张压作为治疗措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: There are scarce data on the association of blood pressure measures with subsequent macular structural rates of change in patients with glaucoma. OBJECTIVE: To investigate the association of baseline blood pressure measures with rates of change of the macular ganglion cell complex in patients with central or moderate to advanced glaucoma damage at baseline. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study, conducted from August 2021 to August 2022, used data from patients in the Advanced Glaucoma Progression Study at the University of California, Los Angeles. Participants were between 39 and 80 years of age and had more than 4 macular imaging tests and 2 or more years of follow-up. EXPOSURES: A diagnosis of glaucoma with either central damage or a visual field mean deviation worse than -6 dB. MAIN OUTCOMES AND MEASURES: The main outcome was the association of blood pressure measures with ganglion cell complex rates of change. Macular ganglion cell complex thickness rates of change were estimated with a bayesian hierarchical model. This model included relevant demographic and clinical factors. Blood pressure measures, intraocular pressure, and their interactions were added to the model to assess the association of baseline blood pressure measures with global ganglion cell complex rates of change. RESULTS: The cohort included 105 eyes from 105 participants. The mean (SD) age, 10-2 visual field mean deviation, and follow-up time were 66.9 (8.5) years, -8.3 (5.3) dB, and 3.6 (0.4) years, respectively, and 67 patients (63.8%) were female. The racial and ethnic makeup of the cohort was 15 African American (14.3%), 23 Asian (21.9%), 12 Hispanic (11.4%), and 55 White (52.4%) individuals based on patient self-report. In multivariable analyses, female sex, history of taking blood pressure medications, higher intraocular pressure, thicker central corneal thickness, shorter axial length, higher contrast sensitivity at 12 cycles per degree, and higher baseline 10-2 visual field mean deviation were associated with faster ganglion cell complex thinning. Lower diastolic blood pressure was associated with faster rates of ganglion cell complex thinning at higher intraocular pressures. For intraocular pressures of 8 and of 16 mm Hg (10% and 90% quantiles, respectively), every 10 mm Hg-lower increment of diastolic blood pressure was associated with 0.011 μm/y slower and -0.130 μm/y faster rates of ganglion cell complex thinning, respectively. CONCLUSIONS AND RELEVANCE: In this cohort study, a combination of lower diastolic blood pressure and higher intraocular pressure at baseline was associated with faster rates of ganglion cell complex thinning. These findings support consideration of evaluating and addressing diastolic blood pressure as a therapeutic measure in patients with glaucoma if supported by appropriate clinical trials.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mohammadzadeh V, Su E, Mohammadi M, et al. Association of Blood Pressure With Rates of Macular Ganglion Cell Complex Thinning in Patients With Glaucoma. JAMA Ophthalmol. 2023. PMID: 36757702. doi:10.1001/jamaophthalmol.2022.6092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。